scholarly journals Detection and Staging of Chronic Obstructive Pulmonary Disease Using a Computed Tomography-based Weakly Supervised Deep Learning Approach

Author(s):  
Jiaxing Sun ◽  
Ximing Liao ◽  
Yusheng Yan ◽  
Xin Zhang ◽  
Jian Sun ◽  
...  

Abstract BackgroundChronic obstructive pulmonary disease (COPD) remains underdiagnosed globally. The coronavirus disease 2019 pandemic has also severely restricted spirometry, the primary tool used for COPD diagnosis and severity evaluation, due to concerns of virus transmission. Computed tomography (CT)-based deep learning (DL) approaches have been suggested as a cost-effective alternative for COPD identification within smokers. The present study aims to develop weakly supervised DL models that utilize CT image data for the automated detection and staging of spirometry-defined COPD among natural population.MethodsA large, highly heterogenous dataset was established comprising 1393 participants recruited from outpatient, inpatient and physical examination center settings of 4 large public hospitals in China. CT scans, spirometry data, demographic data, and clinical information of each participant were collected for the purpose of model development and evaluation. An attention-based multi-instance learning (MIL) model for COPD detection was trained using CT scans from 837 participants and evaluated using a test set comprised of data from 278 non-overlapping participants. External validation of the COPD detection was performed with 620 low-dose CT (LDCT) scans acquired from the National Lung Screening Trial (NLST) cohort. A multi-channel 3D residual network was further developed to categorize GOLD stages among confirmed COPD patients and evaluated using 5-fold cross validation. Spirometry tests were used to diagnose COPD, with stages defined according to the GOLD criteria.ResultsThe attention-based MIL model used for COPD detection achieved an area under the receiver operating characteristic curve (AUC) of 0.934 on the test set and 0.866 on the LDCT subset acquired from NLST. The model exhibited high generalizability across distinct scanning devices and slice thicknesses, with an AUC above 0.90. The multi-channel 3D residual network was able to correctly grade 76.4% of COPD patients in the test set (423/553) using the GOLD scale, with a Cohen’s weighted Kappa of 0.619 for the assessment of GOLD categorization .ConclusionThe proposed chest CT-DL approach can automatically identify spirometry-defined COPD and categorize patients according to the GOLD scale, with clinically acceptable performance. As such, this approach may be a powerful novel tool for COPD diagnosis and staging at the population level.

2018 ◽  
Vol 5 (5) ◽  
pp. 1222
Author(s):  
Pragati Rao D. ◽  
Aruna Talatam ◽  
Chakradhar B. ◽  
Bhargavi K. ◽  
Bhagyaraj A.

Background: Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterised by persistent respiratory symptoms and airflow limitation with varied presentations (bronchitis and emphysema). High resolution computed tomography (HRCT) plays an important role in identifying the various morphologies thereby reducing morbidity and mortality. The aim of the present study was to evaluate the role of high resolution computed tomography in COPD patients. The Objectives of the present study was to differentiate emphysema predominant, airway predominant and mixed phenotypes and to identify other disease processes and complications.Methods: 50 COPD patients attending Respiratory medicine Department, NRI general hospital were advised for chest x-rays and pulmonary function tests. All the patients selected were smokers with no other co-morbid illnesses. Those patients whose chest x-rays showed no other changes except for COPD changes were selected for HRCT chest.Results: Out of 50 COPD patients emphysema predominance was present in 28 patients (56%), bronchitis predominance in 19 patients (38%) and 3(6%) patients had mixed pattern. In emphysema centriacinar pattern was commonly seen (42.9%), paraseptal in 35.71%, panacinar in 3.57% and bullae in 17.8% cases. All the patients were chronic smokers with pack years >20. All are males with average age above 45 years. Emphysema was common in elderly patients with age above 50 years. Chronic bronchitis is predominantly seen in the age group 40-50 years. Additional diagnoses like bronchiectasis, mass, ILD were identified in 28% cases.Conclusions: HRCT plays a significant role in COPD patients in differentiating phenotypes which have different modes of therapy. Other subtle changes in lungs which cannot be identified on chest x ray are discernible on HRCT. Early identification of complications reduces morbidity and mortality.


2021 ◽  
Author(s):  
Sang Won Park ◽  
Myoung-Nam Lim ◽  
Woo Jin Kim ◽  
So Hyeon Bak

Abstract BackgroundChest computed tomography(CT) is a widely used method to assess morphological and dynamic abnormalities in chronic obstructive pulmonary disease (COPD). The small pulmonary vascular cross-section (CSA), quantitatively extracted from volumetric CT, is a reliable indicator for predicting pulmonary vascular changes. CSA is associated with the severity of symptoms, pulmonary function tests (PFT) and emphysema and in COPD patients the severity increases over time. However, there are few studies of changes in vascular during longitudinal follow-up in COPD patients. We analyzed the correlation longitudinal changes in pulmonary vascular parameters with clinical parameters in COPD patients.Materials and MethodsA total of 288 subjects with COPD were investigated during follow up period up to 6 years. CT images were classified into five subtypes from normal to severe emphysema according to percentage of low-attenuation areas less than -950 and -856 Hounsfield units (HU) on inspiratory and expiratory CT (LAA-950, LAA-856exp). Total number of vessels (Ntotal) and total number of vessels with area less than 5 mm2 (N<5mm) per 1 cm2 of lung surface area (LSA) were measured at 6 mm from the pleural surface.ResultsNtotal/LSA and N<5mm/LSA changed from 1.16±0.27 to 0.87±0.2 and from 1.02±0.22 to 0.78±0.22, respectively, during Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage progression. Both parameters changed from normal to severe emphysema according to CT subtype from 1.39±0.21 to 0.74±0.17 and from 1.18±0.19 to 0.67±0.15, respectively. LAA-950 and LAA-856exp were negatively correlated with Ntotal/LSA (r=-0.738, -0.529) and N<5mm /LSA (r=-0.729, -0.497). On the other hand, pulmonary function test (PFT) results showed a weak correlation with Ntotal/LSA and N<5mm/LSA (r=0.205, 0.210). The depth in CT subtypes for longitudinal change both Ntotal/LSA and N<5mm/LSA was (-0.032, -0.023) and (-0.027) in normal and SAD, respectively.ConclusionsQuantitative computed tomography features faithfully reflected pulmonary vessel alterations, showing in particular that pulmonary vascular alteration started.Trial registrationWe obtained the written informed consent from all participants in this study and the approval for all processes by our institution Institutional Review Board.


Author(s):  
Sreekanth Mohan ◽  
Maryam Almutairi ◽  
Roaa Alnaimi ◽  
Taif Alshehri ◽  
Winnie Philip ◽  
...  

Aims: The aim of the study was to estimate the incidence of Community-acquired pneumonia (CAP) among patients with chronic obstructive pulmonary disease (COPD). Study Design:  A retrospective cohort study. Place and Duration of Study: King Abdulaziz Medical City in Riyadh between January 2016 to March 2018. Methodology: From the medical file, we identified patients with COPD diagnosis who admitted to the hospital. Then we identified the patient who develop CAP after the diagnosis date of the COPD. Other variables such as demographic factors, clinical outcome, comorbidity disease, length of stay in the hospital, and mortality were identified for each patient using their electronic medical file. Results: Out of 363 COPD patients, 122 (33%) had developed CAP after the date of COPD diagnosis.  Based on patient characteristics, the mean age of them was 75.39 years SD was 9.76 and 65% of the patients were female. The available evidence indicates that the mortality rate was n=22 (18.0%). Among those patient, 33 patients were admitted to ICU (27.0%) the rest of patients either wards n= 59 (48.4%) or both n=28 (23.0%). Among our study population, 97.4% had hypertension, 88.6% of the patients had diabetes, and 28.9% had renal failure.  Majority of the study population have been placed on non-invasive ventilation n=94 (77.0%). Conclusion: This study has been shown that COPD patients had increased risk of CAP. Patients who have multiple comorbidity diseases and got CAP with COPD have a higher risk of morbidities and mortality rate, especially elderly patients.Mention the design of the study here.


2020 ◽  
Vol 29 (2) ◽  
pp. 864-872
Author(s):  
Fernanda Borowsky da Rosa ◽  
Adriane Schmidt Pasqualoto ◽  
Catriona M. Steele ◽  
Renata Mancopes

Introduction The oral cavity and pharynx have a rich sensory system composed of specialized receptors. The integrity of oropharyngeal sensation is thought to be fundamental for safe and efficient swallowing. Chronic obstructive pulmonary disease (COPD) patients are at risk for oropharyngeal sensory impairment due to frequent use of inhaled medications and comorbidities including gastroesophageal reflux disease. Objective This study aimed to describe and compare oral and oropharyngeal sensory function measured using noninstrumental clinical methods in adults with COPD and healthy controls. Method Participants included 27 adults (18 men, nine women) with a diagnosis of COPD and a mean age of 66.56 years ( SD = 8.68). The control group comprised 11 healthy adults (five men, six women) with a mean age of 60.09 years ( SD = 11.57). Spirometry measures confirmed reduced functional expiratory volumes (% predicted) in the COPD patients compared to the control participants. All participants completed a case history interview and underwent clinical evaluation of oral and oropharyngeal sensation by a speech-language pathologist. The sensory evaluation explored the detection of tactile and temperature stimuli delivered by cotton swab to six locations in the oral cavity and two in the oropharynx as well as identification of the taste of stimuli administered in 5-ml boluses to the mouth. Analyses explored the frequencies of accurate responses regarding stimulus location, temperature and taste between groups, and between age groups (“≤ 65 years” and “> 65 years”) within the COPD cohort. Results We found significantly higher frequencies of reported use of inhaled medications ( p < .001) and xerostomia ( p = .003) in the COPD cohort. Oral cavity thermal sensation ( p = .009) was reduced in the COPD participants, and a significant age-related decline in gustatory sensation was found in the COPD group ( p = .018). Conclusion This study found that most of the measures of oral and oropharyngeal sensation remained intact in the COPD group. Oral thermal sensation was impaired in individuals with COPD, and reduced gustatory sensation was observed in the older COPD participants. Possible links between these results and the use of inhaled medication by individuals with COPD are discussed.


2020 ◽  
Vol 24 (4) ◽  
pp. 80-86
Author(s):  
V. I. Trofimov ◽  
D. Z. Baranov

BACKGROUND: a comparative analysis of laboratory and instrumental tests at patients with bronchial obstructive diseases seems very actual due to the wide prevalence of these diseases. THE AIM: to evaluate characteristics of spirometry as well as allergic (total IgE, sputum eosinophils) and infectious (blood and sputum leucocytes, ESR, CRP, fibrinogen) inflammation markers at patients with bronchial obstructive diseases. PATIENTS AND METHODS: 104 case histories of patients with bronchial asthma, chronic obstructive pulmonary disease and overlap were analyzed including age, duration of smoking (pack-years), laboratory (clinical blood test, biochemical blood test, general sputum analysis, sputum culture) and instrumental (spirometry, body plethysmography, echocardiography) tests. Data were processed statistically with non-parametric methods. RESULTS: COPD patients were older than other groups’ patients, had the highest pack-years index. ACO patients were marked with maximal TLC and Raw, minimal FEV1, FEF25-75, FEV1/FVC. Patients with COPD had the highest inflammation markers (leucocyte count, CRP, fibrinogen). CONCLUSION: high active inflammation may cause severe lower airways possibility disorders at patients with COPD. Data related to a possible role of K. pneumoniaе in the pathogenesis of eosinophilic inflammation in lower airways are of significant interest. Patients with ACO occupy an intermediate position between asthma and COPD patients based on clinical and functional features.


Sign in / Sign up

Export Citation Format

Share Document